StarFish Medical is featured in Devising precision, an article in LifeSciences BC’s annual magazine, Life Sciences 2018.
“We’re a high-technology R&D company,” says StarFish’s CEO, Scott Phillips. Right now, for example, it’s working with a California company that focuses on stem cell therapies for amyotrophic lateral sclerosis, or ALS, commonly known as Lou Gehrig’s disease. Devices to locate markers attached to cancer cells, which allows for individualized treatment regimens, are another emerging area.
“That’s definitely been an area we’ve seen a rise in,” Phillips says. “Sometimes you need to deliver these specialized therapies to a [specific] part of the body.”
The magazine is published by Business in Vancouver Media Group in partnership with LifeSciences BC. Please click the link above to open the magazine and learn about BC successes this past year. If you would like to receive a printed copy, please email email@example.com.